Mar 04, 2024 / 03:00PM GMT
Cornelis de Jong - Novozymes A/S-Independent Chairman
Dear shareholders, welcome to this brief Extraordinary Shareholders' Meeting following the completed combination between Novozymes and Chr. Hansen. Now we're joined as one company, Novonesis, the name you see on today's agenda.
The Board of Directors has been looking forward to hosting you here at the newly opened innovation campus in Hørsholm, north of Copenhagen. The campus has been built as a future-oriented center for innovation, knowledge sharing and customer support, especially in food and health, and it truly reflects what we can achieve with this combination. Thank you to everyone here in person and those of you watching the webcast.
In December 2022, 2 strong companies agreed to combine with the ambition of creating a world-leading biosolutions partner. Our shareholders approved the proposed combination at Extraordinary Shareholder Meetings in March 2023. And on the 29th of January this year, the combination was registered by the Danish Business Authority. So yes, the combination is now a
Novozymes A/S Extraordinary Shareholders Meeting Transcript
Mar 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers